サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
表紙：マイクロカプセル化オメガ3粉末の世界市場-2023年～2030年
市場調査レポート
商品コード
1359946

マイクロカプセル化オメガ3粉末の世界市場-2023年～2030年

Global Microencapsulated Omega-3 Powders Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 212 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マイクロカプセル化オメガ3粉末の世界市場-2023年～2030年
出版日: 2023年10月11日
発行: DataM Intelligence
ページ情報: 英文 212 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要：

マイクロカプセル化オメガ3粉末の世界市場は、2022年に166億米ドルに達し、2023-2030年の予測期間中にCAGR 7.9％で成長し、2030年までに305億米ドルに達すると予測されています。

オメガ3脂肪酸は、心臓血管の健康をサポートする可能性、特に心臓病のリスクを軽減することから、大きな注目を集めています。オメガ3脂肪酸はまた、記憶力の向上や気分の調整など、認知機能の健康増進にも関連しています。消費者が全身の健康に寄与する製品を積極的に求める時代において、マイクロカプセル化オメガ3粉末は便利で効果的な手段を提供します。

さらに、この市場の拡大は、植物ベースの食生活やライフスタイルへのシフトによって後押しされ、植物由来のオメガ3源、特に藻類由来のマイクロカプセル化粉末への需要が高まっています。これは倫理的、環境的、健康的配慮とシームレスに一致するため、市場の成長軌道を後押ししています。

消費者が積極的な健康対策を優先し、実用的な栄養解決策を求め続ける中、マイクロカプセル化オメガ3粉末市場は持続的な拡大態勢にあり、より広範な栄養補助食品業界に価値ある貢献を果たしています。マイクロカプセル化オメガ3粉末の強化食品および飲食品用途は、市場シェアの30％以上を占めています。

同様に、北米がマイクロカプセル化オメガ3粉末市場を独占し、1/3以上の最大市場シェアを獲得しています。米国人がますます健康を優先し、積極的に健康管理を行うようになるにつれて、これらの必須栄養素を供給するマイクロカプセル化オメガ3粉末のようなサプリメントの需要は急増し続けています。

ダイナミクス：

健康とウェルネスへの意識

人々は世界中で、特に日常的な食品を決定する際に、自分自身の健康とウェルネスにより注意を払うようになっています。シンガポール認定評議会の報告書によると、米国では市販薬や栄養・健康食品・飲食品を含む健康関連製品の売上が増加している（2020年から2021年にかけて31%の成長）。

この急成長は、世界の消費者の48％が、日常生活を送る中で健康を維持することを積極的に選択しているためと考えられます。顧客はまた、企業（食品メーカーや小売業者など）や政府機関が地球の健康とウェルビーイングを促進するために積極的な措置を講じることを期待しています。実際、調査対象となった海外の消費者の大多数（72％）は、誰もが健康的な食品を入手しやすい価格で手に入れられるようにするために、企業が果たすべき役割は大きいと考えています。

世界の医療費の増加（2020年には8.8％から9.9％へ）、砂糖規制（50カ国が砂糖関税を課した）、表示に関する法律（OECD加盟4カ国が栄養表示を実施）などは、健康的なライフスタイルに対する消費者需要の増加をもたらしたいくつかの動向に過ぎず、その結果、マイクロカプセル化オメガ3粉末の需要が高まっています。

安定性と保存性の向上

安定性の向上と保存期間の延長は、マイクロカプセル化オメガ3粉末市場を支える特徴的で影響力のある力となっています。オメガ3脂肪酸は、その健康増進特性で有名ですが、歴史的に劣化や酸化に対する感受性に関する問題に直面してきました。こうした課題により、オメガ3サプリメントや強化食品の腐敗や効果の低下がしばしば生じています。

市場の主要企業は、革新的にポートフォリオを拡大しています。2022年9月、フリースラント・カンピナ社（FrieslandCampina）は、新生児用ミルクに使用される3種類のマイクロカプセル化長鎖多価不飽和脂肪酸（LCPUFA）、2種類のDHA成分と1種類のARA成分を発表しました。DHA成分は藻類油から、ARA成分は菌類油から得られます。両製品ともVana-Sanaシリーズの一部です。

オメガ3の安定性が保証されることで、メーカーは製品のラインナップを多様化することができます。マイクロカプセル化された粉末は、シリアル、スナック、ミール代替シェイクなど、保存期間が延長されたものを含む、より広範な食品や飲食品に組み込むことができます。マイクロカプセル化オメガ3粉末は、製品の品質を損なうことなく、日常的な食品に必須脂肪酸を強化する道を開きます。この変革は、従来の食品を機能的で健康志向の選択肢へと変えます。

消費者の認知度の低さ

マイクロカプセル化オメガ3粉末は、魚油カプセルや液体サプリメントのような確立された形態と比較すると、栄養補助食品の分野に比較的最近加わったものです。そのため、多くの消費者はマイクロカプセル化粉末の存在と利点を知らないかもしれません。消費者は自分が慣れ親しみ、予備知識を持っている選択肢に引き寄せられる傾向があるため、この製品形態に馴染みがないことは大きな課題となり得ます。

マイクロカプセル化オメガ3粉末の利点を伝えるのは、複雑な場合があります。これらの粉末は、安定性の向上、臭いや味の懸念の軽減、オメガ-3脂肪酸の生物学的利用能の向上といった特徴的な利点を提供しますが、消費者にこれらの利点をわかりやすく簡潔に説明することは難しいです。このような複雑さは、消費者が十分な情報に基づいた意思決定を行う妨げとなり、より馴染みのあるサプリメント形態を選ぶようになる可能性があります。

コストの複雑さ

課題の第一の側面は、マイクロカプセル化プロセス自体の複雑さにあります。このプロセスには、オメガ3系油を保護層内に封入し、安定性と生物学的利用能を高める高度な手法が必要となります。これらの手法には、特殊な設備と熟練した労働力が必要であり、そのため生産コストが上昇します。さらに、壁材や安定剤など、カプセル化の手順で使用される原材料は高価な場合があります。

メーカーは、カプセル化技術を改良し、厳格な品質基準を維持し、製品の有効性を保証するために、研究開発に多額の投資を行う必要があります。その結果、マイクロカプセル化オメガ3粉末の製造に関連する費用は、魚油カプセルや液状のような従来のオメガ3サプリメントを上回る傾向があります。

メーカーが高品質のマイクロカプセル化オメガ3粉末を提供することと競合価格を提供することの間で均衡を取ろうとするとき、価格設定の課題が生じます。製造コストの上昇は製品価格の上昇につながることが多く、コスト意識の高い消費者にとって市場の魅力が限定される可能性があります。消費者が節約に熱心で、より低コストのオメガ3サプリメントを選ぶ可能性がある市場では、これは適切な問題となります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 健康とウェルネスへの意識
      • 安定性と保存性の向上
    • 抑制要因
      • 消費者の認知度の低さ
      • コストの複雑さ
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 タイプ別

  • α-リノレン酸
  • エイコサペンタエン酸
  • ドコサヘキサエン酸

第8章 流通チャネル別

  • スーパーマーケット／ハイパーマーケット
  • コンビニエンスストア
  • 専門店
  • eコマース
  • その他

第9章 用途別

  • 栄養補助食品
  • 強化食品・飲料
  • 乳児用調製粉乳
  • 医薬品
  • スポーツ栄養
  • 化粧品・パーソナルケア製品
  • その他

第10章 エンドユーザー別

  • 小児
  • 成人
  • 高齢者

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • ADM
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • FrieslandCampina
  • BASF SE
  • KD Pharma Group
  • Novotech Nutraceuticals Inc.
  • WINCOBEL
  • Aker BioMarine
  • Croda International Plc
  • DSM
  • Ecovatec Solutions Inc.

第14章 付録

目次
Product Code: FB6989

Overview:

Global Microencapsulated Omega-3 Powders Market reached US$ 16.6 billion in 2022 and is expected to reach US$ 30.5 billion by 2030, growing with a CAGR of 7.9% during the forecast period 2023-2030.

Omega-3 fatty acids have garnered substantial attention due to their potential in supporting cardiovascular health, notably by mitigating the risk of heart diseases. They are also associated with cognitive health enhancements, including memory improvement and mood regulation. In an era where consumers actively seek products that contribute to their overall well-being, microencapsulated omega-3 powders offer a convenient and effective avenue.

Additionally, the market's expansion is bolstered by the shift towards plant-based diets and lifestyles, fostering a growing demand for plant-derived omega-3 sources, particularly microencapsulated powders derived from algae. This aligns seamlessly with ethical, environmental, and health considerations, thereby propelling the market's growth trajectory.

As consumers continue to prioritize proactive health measures and seek practical dietary solutions, the microencapsulated omega-3 powders market stands poised for sustained expansion, making a valuable contribution to the broader dietary supplement industry. The fortified food and beverages application of microencapsulated omega-3 powders account for over 30% of the market share.

Similarly, North America dominates the microencapsulated omega-3 powders market, capturing the largest market share of over 1/3rd. As Americans increasingly prioritize their health and proactively manage their well-being, the demand for supplements like microencapsulated omega-3 powders, which deliver these essential nutrients, continues to soar.

Dynamics:

Health and Wellness Awareness

People are paying more attention to their own health and wellness all across the world, especially when making everyday food product decisions. The Singapore Accreditation Council report states that sales of health-related products in the U.S. have increased (31% growth from 2020-2021), including over-the-counter medications and nutritional/healthier food and beverages.

The upsurge can be due to the 48% of global consumers who actively choose to maintain their wellness as they go about their daily activities. Customers also anticipate businesses (such food producers and retailers) and governmental organizations to take proactive steps to advance the health and wellbeing of the planet. In fact, the majority of surveyed international consumers (72%) thought that businesses had a big part to play in making sure that everyone could access healthy food at an accessible price.

The increased global healthcare expenditures (8.8% to 9.9% in 2020), sugar regulations (50 nations imposed sugar tariffs), and label laws (4 OECD countries enforce nutritional labelling) are just a few trends that have led to increased consumer demand towards healthy lifestyles, which in turn, there is a demand for microencapsulated omega-3 powders.

Enhanced Stability and Shelf Life

Improved stability and prolonged shelf life constitute a distinctive and influential force behind the microencapsulated omega-3 powders market. Omega-3 fatty acids, renowned for their health-enhancing properties, have historically faced issues related to susceptibility to degradation and oxidation. These challenges often result in rancid and less effective omega-3 supplements and fortified foods.

Key players in the market are innovatively expanding their portfolios. In September 2022, three microencapsulated long-chain polyunsaturated fatty acids (LCPUFA), two DHA components and one ARA ingredient, have been introduced by FrieslandCampina components for use in newborn milk formulas. The DHA ingredients come from algal oil, while the ARA ingredients come from fungus oil. Both products are part of the Vana-Sana line.

With the assurance of omega-3 stability, manufacturers can diversify their product offerings. Microencapsulated powders can be incorporated into a broader spectrum of food and beverage products, including those with extended shelf lives, such as cereals, snacks, and meal replacement shakes. Microencapsulated omega-3 powders open doors to fortify everyday foods with essential fatty acids without compromising product quality. This transformation turns conventional foods into functional, health-oriented options.

Limited Consumer Awareness

Microencapsulated omega-3 powders represent a relatively recent addition to the dietary supplement arena when compared to more established forms like fish oil capsules or liquid supplements. Consequently, many consumers may not be acquainted with the existence and benefits of microencapsulated powders. The absence of familiarity with this product form can pose a significant challenge, as consumers tend to gravitate toward options they are comfortable with and have prior knowledge.

Conveying the advantages of microencapsulated omega-3 powders can be intricate. While these powders offer distinctive benefits such as heightened stability, diminished odor and taste concerns, and improved bioavailability of omega-3 fatty acids, articulating these advantages to consumers in a straightforward and concise manner can be demanding. This complexity can hinder consumers' ability to make informed decisions and may lead them to opt for more familiar supplement forms.

Cost Complexity

A primary aspect of the challenge lies in the complexity of the microencapsulation process itself. This process entails advanced methodologies to encase omega-3 oils within protective layers, enhancing stability and bioavailability. These methodologies necessitate specialized equipment and a skilled workforce, thereby escalating production expenses. Furthermore, the raw materials utilized in the encapsulation procedure, such as wall materials and stabilizers, can be costly.

Manufacturers are required to make substantial investments in research and development to refine encapsulation technologies, maintain rigorous quality standards, and assure product efficacy. Consequently, the expense associated with manufacturing microencapsulated omega-3 powders tends to surpass that of traditional omega-3 supplements like fish oil capsules or liquid forms.

The pricing challenge arises when manufacturers endeavor to strike an equilibrium between delivering high-quality microencapsulated omega-3 powders and offering competitive pricing. Elevated production costs often translate into higher product prices, which might limit the market's attractiveness to cost-conscious consumers. This becomes a pertinent issue in markets where consumers are keen on economizing and may opt for more budget-friendly omega-3 supplement alternatives.

Segment Analysis:

The global microencapsulated omega-3 powders market is segmented based on type, distribution channel, application, end-user and region.

Fortified Food and Beverages Applications Fuel Surge in Microencapsulated Omega-3 Powders Market

The fortified food and beverages segment held 36.5% in the global market share. Fortified food and beverage choices provide a hassle-free means for individuals to meet their daily nutritional requirements. In today's fast-paced world, many people find it challenging to allocate time or inclination to consume separate dietary supplements. Fortified products like breakfast cereals, dairy alternatives, and functional beverages offer consumers an effortless way to seamlessly integrate crucial nutrients such as omega-3s into their diets.

Consumers are increasingly scrutinizing product labels and seeking out clean, transparent ingredient lists. Microencapsulation facilitates the utilization of natural ingredients and reduces reliance on synthetic preservatives, aligning well with the clean label trend. This aligns with health-conscious consumers who desire clarity about what they are consuming.

For manufacturers, fortifying foods and beverages with microencapsulated omega-3 powders presents prospects for innovation and setting their products apart. In a competitive landscape, offering fortified choices can distinguish brands and attract health-focused consumers, potentially leading to increased market share and brand loyalty.

In March 2021, Netherlands company Lus Health Ingredients (also known as LUS), which creates sustainable and plant-based ingredients, increased the selection of fat powders that are rich in omega 3, 6, and 9. The company claims that a rising number of consumers do not want to ingest dairy, glucose syrups, maltodextrin, or other components that are typically found in fat powders, which are most frequently used by those who follow a ketogenic diet.

Geographical Penetration:

Adoption of Healthy Supplements in the U.S.

The North America microencapsulated omega-3 powders market held the largest market share of 40.3% in 2022 in the microencapsulated omega-3 powders market analysis. A significant contributor to the rise in interest in microencapsulated omega-3 powders is the growing focus on health and wellbeing in the U.S. End users in this region are actively looking for products that provide a range of health benefits as they become more health conscious.

The mental health advantages of these essential fatty acids are also well documented, particularly aiding in cognitive function and possibly mood enhancement. North America's demographic landscape includes a significant aging population, with older individuals placing a premium on health and wellness. Omega-3s, with their associations with cognitive preservation and joint health, hold particular appeal for seniors.

People in the U.S. are prone to various chronic diseases. Data from TechTarget, Inc.'s Xtelligent Healthcare studies show that 133 million Americans, or 43% of the population, suffer from one or more chronic conditions. Patients with chronic illnesses and the people they care about suffer from a heavy load. Hence, consumers are opting for fortified food and beverages.

Competitive Landscape

The major global players in the market include ADM, FrieslandCampina, BASF SE, KD Pharma Group, Novotech Nutraceuticals Inc., WINCOBEL, Aker BioMarine, Croda International Plc, DSM and Ecovatec Solutions Inc.

COVID-19 Impact Analysis

The microencapsulated omega-3 powders market felt the consequences of the COVID-19 pandemic, experiencing both immediate disruptions and lasting alterations in consumer behavior and industry operations. Initially, the pandemic triggered supply chain hiccups as global trade restrictions and factory closures hampered the procurement of essential raw materials and the production of these powders. This led to bottlenecks in manufacturing and short-term price hikes as production costs increased.

Concurrently, a surge in demand for omega-3 powders driven by health-conscious consumers responding to the health crisis resulted in some suppliers struggling to meet the sudden upswing in orders. Nonetheless, as the pandemic evolved, the market adapted. Manufacturers expanded their production capacities, streamlined supply chains, and invested in innovative encapsulation technologies to meet surging demand.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict has introduced complex challenges to the microencapsulated omega-3 powders market, primarily by disrupting the global supply chain. Ukraine, a key player in the production of sunflower oil, a significant source of omega-3 fatty acids, has experienced agricultural disruptions and trade uncertainties. These disruptions have the potential to create shortages and price fluctuations for crucial raw materials required for the microencapsulation process.

Beyond the immediate supply chain disruptions, the Russia-Ukraine conflict has catalyzed changes in consumer behavior and prompted strategic responses from businesses in the microencapsulated omega-3 powders market. During times of geopolitical uncertainty, consumers often gravitate toward products perceived as stable and trustworthy. This trend may potentially boost demand for omega-3 powders, given their recognized health benefits.

By Type

  • Alpha-linolenic Acid
  • Eicosapentaenoic Acid
  • Docosahexaenoic Acid

By Distribution channel

  • Supermarkets/Hypermarkets
  • Convenience Stores
  • Specialty Stores
  • E-Commerce
  • Others

By Application

  • Dietary Supplements
  • Fortified foods and beverages
  • Infant Formula
  • Pharmaceuticals
  • Sports Nutrition
  • Cosmetics and Personal Care Products
  • Others

By End-User

  • Children
  • Adults
  • Seniors

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In September 2022, Three microencapsulated long-chain polyunsaturated fatty acids (LCPUFA), two DHA components and one ARA ingredient, have been launched by FrieslandCampina components for use in newborn milk formulas. The DHA ingredients come from algal oil, while the ARA ingredients come from fungus oil. Both products are part of the Vana-Sana line.
  • In April 2020, DSM introduced two new, premium lipid powders for newborn nourishment called DHASCO®-B and ARASCO® powders, each of which offers a minimum of 110 mg/g of either DHA (docosahexaenoic acid) or ARA (arachidonic acid). These powders, which can be added to infant and subsequent formulae as well as growing-up milk products, contain safe and acceptable sources of vegetarian DHA omega-3 and ARA omega-6.
  • In September 2020, Evonik has announced the extension of its AvailOm® platform of high-load omega-3 powders to support the development of superior algal or fish-oil-based dietary supplement formulations by nutraceutical firms. Every one of the three grades is designed to meet the special application needs for good ageing, pregnancy, and motherhood, as well as the lifestyle requirements of consumer groups including vegans and vegetarians.

Why Purchase the Report?

  • To visualize the global microencapsulated omega-3 powders market segmentation based on type, distribution channel, application, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of microencapsulated omega-3 powders market-level with all segments.
  • The PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global Microencapsulated Omega-3 Powders Market Report would provide approximately 69 tables, 73 figures and 212 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet By Type
  • 3.2. Snippet By Distribution Channel
  • 3.3. Snippet By Application
  • 3.4. Snippet By End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Health and Wellness Awareness
      • 4.1.1.2. Enhanced Stability and Shelf Life
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Consumer Awareness
      • 4.1.2.2. Cost Complexity
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Alpha-linolenic Acid*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Eicosapentaenoic Acid
  • 7.4. Docosahexaenoic Acid

8. By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 8.2. Market Attractiveness Index, By Distribution Channel
  • 8.3. Supermarkets/Hypermarkets*
    • 8.3.1. Introduction
    • 8.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.4. Convenience Stores
  • 8.5. Specialty Stores
  • 8.6. E-Commerce
  • 8.7. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Dietary Supplements*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Fortified foods and beverages
  • 9.4. Infant Formula
  • 9.5. Pharmaceuticals
  • 9.6. Sports Nutrition
  • 9.7. Cosmetics and Personal Care Products
  • 9.8. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Children*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Adults
  • 10.4. Seniors

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Russia
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. ADM
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. FrieslandCampina
  • 13.3. BASF SE
  • 13.4. KD Pharma Group
  • 13.5. Novotech Nutraceuticals Inc.
  • 13.6. WINCOBEL
  • 13.7. Aker BioMarine
  • 13.8. Croda International Plc
  • 13.9. DSM
  • 13.10. Ecovatec Solutions Inc.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us